According to Charles Edwards, Infleqtion’s SPAC partner CCCX has filed an S-4, which he says implies roughly a 90% probability the deal will close (source: Charles Edwards on X, Jan 7, 2026). Edwards stated that upon completion, Infleqtion would be the first publicly traded neutral-atom quantum company and the only public firm with commercial leadership across both quantum computing and precision sensing (source: Charles Edwards on X, Jan 7, 2026). Edwards added that the listing would make Infleqtion the global publicly listed market leader in quantum while trading at about half the valuation of peers IONQ and RGTI, highlighting a peer-relative valuation setup for traders (source: Charles Edwards on X, Jan 7, 2026).

According to @StockMarketNerd, short sellers aiming for asymmetric downside should target weaker names like IONQ and RGTI rather than leaders NVDA and PLTR, emphasizing risk-reward efficiency for bears (source: @StockMarketNerd). According to @StockMarketNerd, NVDA and PLTR are described as elite, expensive, and thriving operators, while IONQ and RGTI are characterized as probable zeros with no near-term path to a viable product, making the latter a lower-resistance short, in their view (source: @StockMarketNerd). According to @StockMarketNerd, betting against category leaders requires timing industry cycle deceleration, whereas shorting structurally weaker firms is anchored in fundamentals and product viability risks (source: @StockMarketNerd). According to @StockMarketNerd, a practical trading takeaway is to concentrate short exposure in weaker quantum-computing equities (IONQ, RGTI) rather than AI leaders (NVDA, PLTR) if seeking downside, while recognizing higher volatility and sizing accordingly (source: @StockMarketNerd). According to @StockMarketNerd, the comment references a Burry-style short mindset and frames the choice as minimizing voluntary resistance by avoiding fights against strong leaders (source: @StockMarketNerd).